Liquidia Corp Files 8-K on Director Changes and Compensation

Ticker: LQDA · Form: 8-K · Filed: Jul 1, 2025

Sentiment: neutral

Topics: corporate-governance, executive-compensation, filing

TL;DR

Liquidia Corp filed an 8-K on July 1, 2025, covering director changes and executive pay. No specific numbers yet.

AI Summary

On July 1, 2025, Liquidia Corporation filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing also includes financial statements and exhibits, though specific financial figures or new appointments are not detailed in this summary.

Why It Matters

Changes in a company's board and executive compensation can signal shifts in strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing is primarily procedural, reporting on board and compensation matters without immediate financial implications.

Key Players & Entities

FAQ

What specific changes were made to the board of directors?

The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' but does not specify the names or details of these changes in the provided text.

What are the details of the new compensatory arrangements?

The filing mentions 'Compensatory Arrangements of Certain Officers' but does not provide specific details or dollar amounts for these arrangements in the provided text.

Are there any new financial statements included with this filing?

Yes, the filing states 'Financial Statements and Exhibits' are included, but the specific content of these statements is not detailed in the provided text.

What is Liquidia Corporation's principal executive office address?

Liquidia Corporation's principal executive offices are located at 419 Davis Drive, Suite 100, Morrisville, North Carolina 27560.

What is the SIC code for Liquidia Corporation?

The Standard Industrial Classification (SIC) code for Liquidia Corporation is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 1, 2025 regarding Liquidia Corp (LQDA).

View full filing on EDGAR

View on Read The Filing